Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection

NCT06994975 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT06994975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06994975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection
Lead sponsor
Huashan Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
November 3, 2025
Completion date
June 30, 2028
Enrollment
890 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke